Battelle’s Post

A new era of personalized medicine is upon us. Gene therapies and nanomedicines are at the forefront of this revolution and are changing how we approach disease treatment and prevention. Read this Inside Battelle blog to get smarter on the subject: https://okt.to/kyDB7U

Gene therapies and nanomedicines are revolutionizing the way we approach disease treatment and prevention. Our new blog from Anthony Duong Ph.D. dives into the convergence of these transformative tools and what to expect from a regulatory perspective. #GeneTherapies #Nanomedicine https://okt.to/3tgBdI

Gene therapies and nanomedicines are revolutionizing the way we approach disease treatment and prevention. Our new blog from Anthony Duong Ph.D. dives into the convergence of these transformative tools and what to expect from a regulatory perspective. #GeneTherapies #Nanomedicine https://okt.to/KimXzS

Gene therapies and nanomedicines are revolutionizing the way we approach disease treatment and prevention. Read more from Anthony Duong Ph.D. as he dives into the convergence of these transformative tools and what to expect from a regulatory perspective. #GeneTherapies #Nanomedicine https://okt.to/AeqsBC

Gene therapies and nanomedicines are revolutionizing the way we approach disease treatment and prevention. The Inside Battelle blog from Anthony Duong explains. #GeneTherapies #Nanomedicine https://okt.to/sTXkwR

Gene therapies and nanomedicines are revolutionizing the way we approach disease treatment and prevention. The Inside Battelle blog from Anthony Duong explains. #GeneTherapies #Nanomedicine https://okt.to/3jc6OM

Gene therapies and nanomedicines are revolutionizing the way we approach disease treatment and prevention. Read more from Anthony Duong Ph.D. as he dives into the convergence of these transformative tools and what to expect from a regulatory perspective. #GeneTherapies #Nanomedicine https://okt.to/Rk1vLu

It's a new world and gene therapies and nanomedicines are shaping the future of personalized medicine. Battelle scientists have created the HIT SCAN system, a delivery vehicle platform containing nanocarriers that can serve as components of new genetic drug products. But how do we navigate the regulatory pathways to realize their full potential? In this new Inside Battelle blog, Anthony Duong explores this topic in depth. #GeneticNanomedicines #PrecisionMedicine https://okt.to/IF4BZ5

During Advanced Therapies Europe 2023, Drug Discovery World asked attendees: what is most important to scale from discovery to commercialisation of cell and gene therapies (CGTs)? Dr Matthew Lakelin shared his insights in this interview: https://loom.ly/zBYkf_M #CGT #DDW #Scaleup #Commercialization #ATE23

this is a really great summary of the challenges faced by companies developing novel cell and gene therapies (CGTs). Cost is a major hurdle, with biomanufacturing making up a large portion of that cost due to scale (small-batch production), media (recombinant growth factors and expensive proprietary formulations) and yield. This marks such a huge opportunity for B2B companies working to support cultured meat (or cellular agriculture in general). #biotech #cultivatedmeat #cellularagriculture #cellandgenetherapy #partnership